Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Teva
Merck
Farmers Insurance
Mallinckrodt
Citi
Fuji
Deloitte
US Department of Justice
UBS

Generated: February 19, 2018

DrugPatentWatch Database Preview

TEFLARO Drug Profile

« Back to Dashboard

When do Teflaro patents expire, and what generic alternatives are available?

Teflaro is a drug marketed by Allergan Sales Llc and is included in one NDA. There are five patents protecting this drug and one Paragraph IV challenge.

This drug has sixty-six patent family members in thirty-two countries.

The generic ingredient in TEFLARO is ceftaroline fosamil. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ceftaroline fosamil profile page.
Summary for TEFLARO
International Patents:66
US Patents:5
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 12
Clinical Trials: 12
Patent Applications: 11
Drug Prices:see details
DailyMed Link:TEFLARO at DailyMed
Drug patent expirations by year for TEFLARO
Pharmacology for TEFLARO

US Patents and Regulatory Information for TEFLARO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan Sales Llc TEFLARO ceftaroline fosamil POWDER;IV (INFUSION) 200327-001 Oct 29, 2010 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Allergan Sales Llc TEFLARO ceftaroline fosamil POWDER;IV (INFUSION) 200327-001 Oct 29, 2010 RX Yes No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Allergan Sales Llc TEFLARO ceftaroline fosamil POWDER;IV (INFUSION) 200327-002 Oct 29, 2010 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Allergan Sales Llc TEFLARO ceftaroline fosamil POWDER;IV (INFUSION) 200327-002 Oct 29, 2010 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Allergan Sales Llc TEFLARO ceftaroline fosamil POWDER;IV (INFUSION) 200327-001 Oct 29, 2010 RX Yes No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Allergan Sales Llc TEFLARO ceftaroline fosamil POWDER;IV (INFUSION) 200327-001 Oct 29, 2010 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Allergan Sales Llc TEFLARO ceftaroline fosamil POWDER;IV (INFUSION) 200327-001 Oct 29, 2010 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Allergan Sales Llc TEFLARO ceftaroline fosamil POWDER;IV (INFUSION) 200327-001 Oct 29, 2010 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Allergan Sales Llc TEFLARO ceftaroline fosamil POWDER;IV (INFUSION) 200327-002 Oct 29, 2010 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Allergan Sales Llc TEFLARO ceftaroline fosamil POWDER;IV (INFUSION) 200327-002 Oct 29, 2010 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for TEFLARO
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Injection 400 mg/vial and 600 mg/vial ➤ Subscribe 10/29/2014

International Patents for TEFLARO

Supplementary Protection Certificates for TEFLARO

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1043327/01 Switzerland ➤ Sign Up PRODUCT NAME: CEFTAROLIN FOSAMIL; REGISTRATION NO/DATE: SWISSMEDIC 62672 29.08.2013
0568 Netherlands ➤ Sign Up PRODUCT NAME: CEFTAROLINE FOSAMIL OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT ERVAN; REGISTRATION NO/DATE: EU/1/12/785/001 20120823
134 Luxembourg ➤ Sign Up PRODUCT NAME: CEFTAROLINE FOSAMIL ET SES DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (ZINFORO)
C/GB13/004 United Kingdom ➤ Sign Up PRODUCT NAME: CEFTAROLINE FOSAMIL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/12/785/001 20120823
2013 00003 Denmark ➤ Sign Up
2 Finland ➤ Sign Up
13/001 Ireland ➤ Sign Up PRODUCT NAME: CEFTAROLINE FOSAMIL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTRATION NO/DATE: EU/1/12/785/001 20120823
C0008 France ➤ Sign Up PRODUCT NAME: CEFTAROLINE FOSAMIL, SES ESTERS OU SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/12/785/001 20120823
90003-0 Sweden ➤ Sign Up PRODUCT NAME: CEFTAROLINFOSAMIL; REG. NO/DATE: EU/1/12/785/001 20120823
00568 Netherlands ➤ Sign Up PRODUCT NAME: CEFTAROLINE FOSAMIL OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT ERVAN; REGISTRATION NO/DATE: EU/1/12/785/001 00120823
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Julphar
Medtronic
Healthtrust
Express Scripts
Dow
US Department of Justice
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot